Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-25-000271
Filing Date
2025-01-08
Accepted
2025-01-08 16:11:32
Documents
2
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1759
2 SANDERSPOA1.8 sanders_poa2024.txt EX-24 3138
  Complete submission text file 0001562180-25-000271.txt   6583
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 480 PLEASANT STREET SUITE C-400 WATERTOWN MA 02472
Business Address
Sanders Reginald J. (Reporting) CIK: 0002048275 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 25518665